Cite
Recommendations from the COST action CA17116 (SPRINT) for the standardization of perinatal derivative preparation and in vitro testing
MLA
Aleksandar Janev, et al. “Recommendations from the COST Action CA17116 (SPRINT) for the Standardization of Perinatal Derivative Preparation and in Vitro Testing.” Frontiers in Bioengineering and Biotechnology, vol. 11, Nov. 2023. EBSCOhost, https://doi.org/10.3389/fbioe.2023.1258753.
APA
Aleksandar Janev, Asmita Banerjee, Adelheid Weidinger, Jure Dimec, Brane Leskošek, Antonietta Rosa Silini, Tina Cirman, Susanne Wolbank, Taja Železnik Ramuta, Urška Dragin Jerman, Assunta Pandolfi, Roberta Di Pietro, Michela Pozzobon, Bernd Giebel, Günther Eissner, Polonca Ferk, Ingrid Lang-Olip, Francesco Alviano, Olga Soritau, … Mateja Erdani Kreft. (2023). Recommendations from the COST action CA17116 (SPRINT) for the standardization of perinatal derivative preparation and in vitro testing. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1258753
Chicago
Aleksandar Janev, Asmita Banerjee, Adelheid Weidinger, Jure Dimec, Brane Leskošek, Antonietta Rosa Silini, Tina Cirman, et al. 2023. “Recommendations from the COST Action CA17116 (SPRINT) for the Standardization of Perinatal Derivative Preparation and in Vitro Testing.” Frontiers in Bioengineering and Biotechnology 11 (November). doi:10.3389/fbioe.2023.1258753.